Stevanato Group Spa
Open
$16.77
Prev. Close
$16.77
High
$16.80
Low
$16.77
Market Snapshot
$4.92B
30.1
0.46
$1.19B
Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The company is headquartered in Piombino Dese, Padova and currently employs 6,010 full-time employees. The company went IPO on 2021-07-16. The firm delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The firm operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
emptyResult
Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The company is headquartered in Piombino Dese, Padova and currently employs 6,010 full-time employees. The company went IPO on 2021-07-16. The firm delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The firm operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
Recently from Cashu
Stevanato Group S.p.A. Engages Investors on Drug Delivery Solutions at Upcoming Conference
### Stevanato Group: A Leader in Drug Delivery Solutions Engages with Investors Stevanato Group S.p.A., a key player in the global pharmaceutical, biotechnology, and life sciences sectors, prepares fo…
Stevanato Group S.p.A. Showcases Drug Delivery Leadership at Key 2024 Investor Conferences
Stevanato Group S.p.A. Showcases Leadership in Drug Delivery Solutions at Upcoming Conferences Stevanato Group S.p.A., a leading global provider of drug containment and delivery solutions, prepares to…
Stevanato Group Spa Prepares for Major Healthcare Conferences in Late 2024
Stevanato Group Prepares for Key Healthcare Conferences Stevanato Group S.p.A., a leading provider of drug containment and delivery solutions, is gearing up for its participation in three significant…
Stevanato Group Reports Q3 2024 Revenue Growth Amid Operational Challenges
Stevanato Group Navigates Challenges Amidst Revenue Growth in Q3 2024 Stevanato Group S.p.A., a leading global provider of drug containment and delivery solutions, showcases resilience in its third-qu…